β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1258-1266

  Chen, Chia Hua ^a   Wang, Shui Hua ^b   Liu, Chiung Hui ^a   Wu, Yi Ling ^a   Wang, Wei Jen ^a   Huang, John ^c   Hung, Ji Shiang ^c   Lai, I Rue ^a,c   Liang, Jin Tung ^c   Huang, Min Chuan ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE III; BETA1 INTEGRIN; GLYCOSYLTRANSFERASE; UNCLASSIFIED DRUG; BETA4 GALACTOSYLTRANSFERASE III; BETA4-GALACTOSYLTRANSFERASE III; GALACTOSYLTRANSFERASE; LECTIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CELL; CANCER PATIENT; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE SILENCING; GLYCOSYLATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; AGED; CANCER GRADING; CANCER STAGING; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ADULT; AGED; ANTIGENS, CD29; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EXTRACELLULAR MATRIX; FEMALE; GALACTOSYLTRANSFERASES; GENE EXPRESSION; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84904619284     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu007     Document Type: Article

References (40)

1. Jemal, A. et al. (2011) Global cancer statistics. Cancer J. Clin., 61, 69-90.
2. Chiappa, A. et al. (2009) The management of colorectal liver metastases: expanding the role of hepatic resection in the age of multimodal therapy. Crit. Rev. Oncol. Hematol., 72, 65-75.
3. Garden, O.J. et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut, 55 (suppl. 3), iii1-iii8.
4. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl Acad. Sci. USA, 99, 10231-10233.
5. Carpelan-Holmström, M. et al. (2002) CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res., 22, 2311-2316.
6. Ohyama, C. et al. (1999) Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J., 18, 1516-1525.
7. Fukuda, M. et al. (1999) C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. J. Cell Biol., 147, 467-470.
8. Grabowski, P. et al. (2000) Expression of SIALYL-Le(x) antigen defined by mAb AM-3 is an independent prognostic marker in colorectal carcinoma patients. Int. J. Cancer, 88, 281-286.
9. Shimodaira, K. et al. (1997) Carcinoma-associated expression of core 2 beta-1, 6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res., 57, 5201-5206.
10. Demetter, P. et al. (2008) The galectin family and digestive disease. J. Pathol., 215, 1-12.
11. Lowe, J.B. (2001) Glycosylation, immunity, and autoimmunity. Cell, 104, 809-812.
12. Guo, S. et al. (2001) Galactosylation of N-linked oligosaccharides by human beta-1, 4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology, 11, 813-820.
13. Ujita, M. et al. (2000) Poly-N-acetyllactosamine extension in N-glycans and core 2-and core 4-branched O-glycans is differentially controlled by i-extension enzyme and different members of the beta 1, 4-galactosyltransferase gene family. J. Biol. Chem., 275, 15868-15875.
14. Nishie, T. et al. (2010) Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology, 20, 1311-1322.
15. Tokuda, N. et al. (2013) β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. Glycobiology, 23, 1175-1183.
16. Quentin, E. et al. (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc. Natl Acad. Sci. USA, 87, 1342-1346.
17. Almeida, R. et al. (1997) A family of human beta4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:beta-nacetylglucosamine beta1, 4-galactosyltransferases, beta4Gal-T2 and beta4Gal-T3. J. Biol. Chem., 272, 31979-31991.
18. Zhao, Y. et al. (2008) Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J., 275, 1939-1948.
19. Lee, S.H. et al. (2009) Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J. Biol. Chem., 284, 17157-17169.
20. Gu, J. et al. (2004) Beta1, 4-N-Acetylglucosaminyltransferase III downregulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras/ERK signaling pathway in PC12 cells. Glycobiology, 14, 177-186.
21. Guo, H.B. et al. (2002) Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res., 62, 6837-6845.
22. Fukuda, M. (1985) Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. Biochim. Biophys. Acta, 780, 119-150.
23. Bellis, S.L. (2004) Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochim. Biophys. Acta, 1663, 52-60.
24. Wong, G.S. et al. (2013) Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br. J. Cancer, 108, 755-761.
25. Lee, M. et al. (2012) Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells. Radiat. Oncol., 7, 47.
26. Zhao, Y. et al. (2006) Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J. Biol. Chem., 281, 38343-38350.
27. Janik, M.E. et al. (2010) Cell migration-the role of integrin glycosylation. Biochim. Biophys. Acta, 1800, 545-555.
28. Pinho, S.S. et al. (2009) The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum. Mol. Genet., 18, 2599-2608.
29. Yamamoto, E. et al. (2009) N-acetylglucosaminyltransferase V regulates extravillous trophoblast invasion through glycosylation of alpha5beta1 integrin. Endocrinology, 150, 990-999.
30. Zhao, Y. et al. (2006) N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration. J. Biol. Chem., 281, 32122-32130.
31. Liu, Y.C. et al. (2011) Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc. Natl Acad. Sci. USA, 108, 11332-11337.
32. Chang, H.H. et al. (2013) β-1, 4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma. Clin. Cancer Res., 19, 1705-1716.
33. Amado, M. et al. (1999) Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim. Biophys. Acta, 1473, 35-53.
34. El-Battari, A. et al. (2003) Different glycosyltransferases are differentially processed for secretion, dimerization, and autoglycosylation. Glycobiology, 13, 941-953.
35. Seko, A. et al. (2008) Activation of beta1, 3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells. J. Biol. Chem., 283, 33094-33100.
36. Lee, P.L. et al. (2009) Association of beta-1, 3-N-acetylglucosaminyltransferase 1 and beta-1, 4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesis. Glycobiology, 19, 655-664.
37. Chen, W.S. et al. (2005) Tumor beta-1, 4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis. Clin. Cancer Res., 11(24 Pt 1), 8615-8622.
38. Ichikawa, T. et al. (1999) Expression of N-acetyllactosamine and beta1, 4-galactosyltransferase (beta4GalT-I) during adenoma-carcinoma sequence in the human colorectum. J. Histochem. Cytochem., 47, 1593-1602.
39. Schultz, M.J. et al. (2012) Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Rev., 31, 501-518.
40. Balog, C.I. et al. (2012) N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. Mol. Cell. Proteomics, 11, 571-585.